Cargando…

Fractal analysis of (11)C-methionine PET in patients with newly diagnosed glioma

BACKGROUND: The present study tested the possible utility of fractal analysis from l-[methyl-(11)C]-methionine (MET) uptake in patients with newly diagnosed gliomas for differentiating glioma, especially in relation to isocitrate dehydrogenase 1 (IDH1) mutation status, and as compared with the conve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maeda, Yukito, Yamamoto, Yuka, Norikane, Takashi, Mitamura, Katsuya, Hatakeyama, Tetsuhiro, Miyake, Keisuke, Nishiyama, Yoshihiro, Kudomi, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572303/ https://www.ncbi.nlm.nih.gov/pubmed/34743250 http://dx.doi.org/10.1186/s40658-021-00418-y

Ejemplares similares

Correlation of 4′-[methyl-(11)C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma
por: Norikane, Takashi, et al.
Publicado: (2021)

Effect of quantitative values on shortened acquisition duration in brain tumor (11)C-methionine PET/CT
por: Morimoto, Masatoshi, et al.
Publicado: (2021)

Quantitative [(99m)Tc]Tc-MDP SPECT/CT correlated with [(18)F]NaF PET/CT for bone metastases in patients with prostate cancer
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

Texture indices of 4′-[methyl-(11)C]-thiothymidine uptake predict p16 status in patients with newly diagnosed oropharyngeal squamous cell carcinoma: comparison with (18)F-FDG uptake
por: Ihara-Nishishita, Ayumi, et al.
Publicado: (2020)

Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria
por: Miyake, Keisuke, et al.
Publicado: (2020)

Comparative evaluation of (18)F-FLT and (18)F-FDG for detecting cardiac and extra-cardiac thoracic involvement in patients with newly diagnosed sarcoidosis
por: Norikane, Takashi, et al.
Publicado: (2017)

Imaging of the appearance time of cerebral blood using [(15)O]H(2)O PET for the computation of correct CBF
por: Kudomi, Nobuyuki, et al.
Publicado: (2013)

A Case of Ewing Sarcoma of the Mandible on (18)F-FDG PET/CT
por: Takami, Yasukage, et al.
Publicado: (2020)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
por: Suzuki, Kenta, et al.
Publicado: (2021)

Interim 4′-[methyl-(11)C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [(18)F]FDG PET
por: Mitamura, Katsuya, et al.
Publicado: (2021)

Applicability of emission-based attenuation map for rapid CBF, OEF, and CMRO(2) measurements using gaseous (15)O-labeled compounds
por: Maeda, Yukito, et al.
Publicado: (2015)

Relationship between [(18)F]FDG PET/CT and metabolomics in patients with colorectal cancer
por: Imajo, Masashi, et al.
Publicado: (2022)

Usefulness of FDG, MET and FLT-PET Studies for the Management of Human Gliomas
por: Miyake, Keisuke, et al.
Publicado: (2012)

Diagnostic Value of (11)C-Methionine (MET) and (18)F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis
por: Shishido, Hajime, et al.
Publicado: (2012)

FDG PET texture indices as imaging biomarkers for epidermal growth factor receptor mutation status in lung adenocarcinoma
por: Ishimura, Mariko, et al.
Publicado: (2023)

(18)F-FDG PET/CT in patients with polymyositis/dermatomyositis: correlation with serum muscle enzymes
por: Arai-Okuda, Hanae, et al.
Publicado: (2020)

Temporal and spatial changes in reactive astrogliosis examined by (18)F-THK5351 positron emission tomography in a patient with severe traumatic brain injury
por: Hatakeyama, Tetsuhiro, et al.
Publicado: (2021)

Disease activity and response to therapy monitored by [(18)F]FDG PET/CT using volume-based indices in IgG4-related disease
por: Mitamura, Katsuya, et al.
Publicado: (2020)

(18)F-FDG PET in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma
por: Kawai, Nobuyuki, et al.
Publicado: (2013)

(18)F-FDG PET/CT Imaging of Primary Hepatic Neuroendocrine Tumor
por: Mitamura, Katsuya, et al.
Publicado: (2015)

NI-15 THE USEFULNESS OF PET IMAGING IN MOLECULAR DIAGNOSIS OF GLIOMA
por: Ogawa, Tomoya, et al.
Publicado: (2019)

Maximum 11C-methionine PET uptake as a prognostic imaging biomarker for newly diagnosed and untreated astrocytic glioma
por: Nakajo, Kosuke, et al.
Publicado: (2022)

STMO-5 Utilization of intraoperative multimodal technologies [PET and 5-ALA] for treating glioblastoma
por: Miyake, Keisuke, et al.
Publicado: (2021)

An analysis of the left top pulmonary vein and comparison with the right top pulmonary vein for lung resection by three-dimensional CT angiography and thin-section images
por: Murota, Makiko, et al.
Publicado: (2023)

Usefulness of Positron Emission Tomographic Studies for Gliomas
por: MIYAKE, Keisuke, et al.
Publicado: (2016)

BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
por: Miyake, Keisuke, et al.
Publicado: (2021)

Sex-specific radiomic features of L-[S-methyl-(11)C] methionine PET in patients with newly-diagnosed gliomas in relation to IDH1 predictability
por: Papp, Laszlo, et al.
Publicado: (2023)

GEN-09 Pursuing the function of microRNA targeting (Pro)renin receptor against glioma
por: Ogawa, Daisuke, et al.
Publicado: (2020)

C-methionine-PET-guided Gamma Knife radiosurgery boost as adjuvant treatment for newly diagnosed glioblastomas
por: Jacobo, Javier A., et al.
Publicado: (2021)

The performance of 11C-Methionine PET in the differential diagnosis of glioma recurrence
por: Xu, Weilin, et al.
Publicado: (2017)

FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis
por: Kameda, Tomohiro, et al.
Publicado: (2022)

(11)C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence
por: Bag, Asim K., et al.
Publicado: (2022)

(18)F-FDG and (11)C-Methionine PET/CT in Newly Diagnosed Multiple Myeloma Patients: Comparison of Volume-Based PET Biomarkers
por: Morales-Lozano, Maria I, et al.
Publicado: (2020)

STMO-15 OUR THERAPEUTIC STRATEGIES FOR GLIOBLASTOMA: INTRAOPERATIVE SUPPORT SYSTEMS [INTRAOPERATIVE MRI, PET, 5-AMINOLEVULINIC ACID (5-ALA)] AND NEOADJUVANT CHEMOTHERAPY
por: Miyake, Keisuke, et al.
Publicado: (2019)

Preoperative [(11)C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas
por: Ninatti, Gaia, et al.
Publicado: (2022)

(11)C-Methionine PET/CT and (18)F-FDG PET/CT in the Evaluation of Adult Alveolar Rhabdomyosarcoma
por: Hiroshima, Yuka, et al.
Publicado: (2023)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

Voxelwise Principal Component Analysis of Dynamic [S-Methyl-(11)C]Methionine PET Data in Glioma Patients
por: Martens, Corentin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2lffugaqr4b9u7v957ifsoahrr